Lasers in Onychomycosis - Trial NCT05415852
Access comprehensive clinical trial information for NCT05415852 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Not yet recruiting. The study focuses on Onychomycosis. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairo University
Timeline & Enrollment
N/A
Jun 25, 2022
Sep 15, 2022
Primary Outcome
Onychomycosis severity index
Summary
Onychomycosis is the most common nail disease, representing more than 50% of all
 onychopathies. Future studies on the absorption spectra of dermatophyte fungi will be needed
 to develop lasers that effectively exploit absorption differences in fungi and dermal tissue.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05415852
Device Trial